EC Number |
Activating Compound |
Reference |
---|
3.4.16.5 | 1-chloro-3-tosylamido-2-heptanone |
10% increase of activity at 10 mM |
679935 |
3.4.16.5 | 3-Phenyl-1-propanol |
inhibits hydrolysis of benzyloxycarbonyl-Phe-Leu, activates hydrolysis of benzyloxycarbonyl-Gly-Phe |
647213 |
3.4.16.5 | antipain |
15 increase of activity at 0.1 mM |
679935 |
3.4.16.5 | CH3-CH2-CH2-CH2-Hg |
mercurials inhibit the hydrolysis of the good substrate benzyloxycarbonyl-L-Phe-L-Leu, the inhibition is repressed by the competitive inhibitors benzyloxycarbonyl-D-Phe-D-Leu-Leu-Phe, trans-cinnamate and acetyl-D-Phe ethyl ester. Aromatic, methyl and ethyl mercurials do not cause complete inactivation with the poor substrates benzyloxycarbonyl-Gly-Phe and benzoyl-Gly-beta,L-phenyllactate. Propyl and butyl-mercurials enhance these activities |
647213 |
3.4.16.5 | CH3-CH2-CH2-Hg |
mercurials inhibit the hydrolysis of the good substrate benzyloxycarbonyl-L-Phe-L-Leu, the inhibition is repressed by the competitive inhibitors benzyloxycarbonyl-D-Phe-D-Leu-Leu-Phe, trans-cinnamate and acetyl-D-Phe ethyl ester. Aromatic, methyl and ethyl mercurials do not cause complete inactivation with the poor substrates benzyloxycarbonyl-Gly-Phe and benzoyl-Gly-beta,L-phenyllactate. Propyl and butyl-mercurials enhance these activities |
647213 |
3.4.16.5 | EDTA |
25% increase of activity at 10 mM |
679935 |
3.4.16.5 | Kar2p, Pdi1p, Ero1p |
co-expression of Kar2p, Pdi1p and Ero1p give a synergistic effect on CPY expression, of which activity is 1.7times higher than that of the control strain |
731493 |
3.4.16.5 | Karp2 |
a single co-expression of Kar2p leads to a 28% enhancement in extracellular CPY activity, relative to the control strain |
731493 |
3.4.16.5 | leupeptin |
20% increase of activity at 0.1 mM |
679935 |
3.4.16.5 | more |
FUSCA, a B3 domain transcription factor that lacks the N-terminal activation and B1 domain 3 activates the phaseolin promoter in the presence of abscisic acid |
682394 |